FindTrial
Sign In

The prevalence, influential factors and intervention of somatic diseases in Chinese patients with chronic schizophrenia

The prevalence, influential factors and intervention of somatic diseases in Chinese patients with chronic schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017044
Enrollment
Unknown
Registered
2018-07-10
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Schizophrenia group:no-intervention
control group:no-intervention
Schizophrenia with diabetes group:intervention on lifestyle

Sponsors

Chaohu Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: patients with DSM-IV diagnosis criteria of schizophrenia aged 18-75 years old;at least 5-year duration of illness

Exclusion criteria

Exclusion criteria: patients with severe neurological diseases or mental retardation, and pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
biochemical indicators of diseases;psychological assessments;Inflammatory cytokines;—

Secondary

MeasureTime frame
Orexin-A;—

Countries

China

Contacts

Public ContactHuanzhong Liu

Chaohu Hospital of Anhui Medical University

huanzhongliu@126.com+86 13855152219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026